AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Novonesis AS

Director's Dealing Feb 12, 2021

3377_rpt_2021-02-12_7d9a2bad-cd5b-491b-bf6c-1f6f0e31949f.pdf

Director's Dealing

Open in Viewer

Opens in native device viewer

Trading by management and close relations of management

In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novozymes reports the following transactions under ISIN DK0060336014, Novozymes B shares under the symbol NZYM B.

Details of the person discharging managerial responsibilities/person closely associated Name Thomas Videbæk

Reason for notification

Position/status Executive Vice President, +1 919 702 6144
Strategy & Business Transformation; People, Sustainability & Brand [email protected]
Initial notification/ Initial notification Ulrik Wu Svare
amendment +45 3077 3187

Details of the issuer

Entity Novozymes A/S
LEI code 529900T6WNZXD2R3JW38

Details of the transaction(s)

Description:
Financial instrument Shares
Identification code ISIN DK0060336014
Nature of the transaction Exercise of share options (purchase)
Place(s) of transaction(s), Place(s) Price(s) Volume(s)
price(s) and volume(s) Novozymes' custody
account
249.40 60,960 shares
Aggregated information Number of shares: 60,960
Average price, DKK: 249.40
Transaction value, DKK: 15,203,424
Date of the transaction 2021-02-11 (10:11:00 CET)

February 12, 2021 Company announcement No. 06

Contact information [email protected]

Tobias Cornelius Björklund +45 3077 8682 [email protected]

Carl Ahlgren

[email protected]

About Novozymes

Novozymes is the world leader in biological solutions. Together with customers, partners and the global community, we improve industrial performance while preserving the planet's resources and helping build better lives. As the world's largest provider of enzyme and microbial technologies, our bioinnovation enables higher agricultural yields, low-temperature washing, energyefficient production, renewable fuel and many other benefits that we rely on today and in the future. We call it Rethink Tomorrow. www.novozymes.com

Novozymes A/S CVR number: 10 00 71 27 LEI: 529900T6WNZXD2R3JW38

Novozymes A/S Krogshoejvej 36 2880 Bagsvaerd Denmark

Phone: +45 4446 0000

Details of the person discharging managerial responsibilities/person closely associated

Name Thomas Videbæk

Reason for notification

Position/status Executive Vice President,
Strategy & Business Transformation; People, Sustainability & Brand
Initial notification/ Initial notification
amendment

Details of the issuer

Entity Novozymes A/S
LEI code 529900T6WNZXD2R3JW38

Details of the transaction(s)

Description:
Financial instrument Shares
Identification code ISIN DK0060336014
Nature of the transaction Sale of shares
Place(s) of transaction(s),
price(s) and volume(s) Place(s) Price(s) Volume(s)
See appendix See appendix See appendix
Aggregated information Number of shares: 60,960
Average price, DKK: 397.00
Transaction value, DKK: 24,201,135.61
Date of the transaction 2021-02-11

Appendix

Volume Price Venue
60708 397 Off Exchange
96 397.1 Citi Match
60 397.1 Citi Match
96 397 Citidel Connect Europe

Talk to a Data Expert

Have a question? We'll get back to you promptly.